Insight Molecular Diagnostics (IMDX) Share-based Compensation Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) Share-based Compensation Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn | 3.48% |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn | -1.05% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 1.55% |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn | 25.99% |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn | 23.86% |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn | -73.26% |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn | -11.69% |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn | 8.59% |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn | -20.63% |
| 10 | Insight Molecular Diagnostics | 170.35 Mn | 141.42 Mn | 15,000.00 | 84.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.05% |
| Dec 31, 2025 | -34.95% |
| Sep 30, 2025 | 26.90% |
| Jun 30, 2025 | 15.06% |
| Mar 31, 2025 | -38.26% |
| Dec 31, 2024 | -39.86% |
| Sep 30, 2024 | -37.58% |
| Jun 30, 2024 | -42.18% |
| Mar 31, 2024 | -58.28% |
| Dec 31, 2023 | -21.09% |
| Sep 30, 2023 | -30.15% |
| Jun 30, 2023 | -15.06% |
| Mar 31, 2023 | -3.81% |
| Dec 31, 2022 | -1.74% |
| Sep 30, 2022 | 57.06% |
| Jun 30, 2022 | 47.12% |
| Mar 31, 2022 | 43.09% |
| Dec 31, 2021 | 62.14% |
| Sep 30, 2021 | 75.20% |
| Jun 30, 2021 | 72.51% |